STOCK TITAN

Bausch + Lomb Form 4: CFO Tax-Settlement Transaction Disclosed

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Bausch + Lomb Corporation (BLCO) filed a Form 4 showing EVP & CFO Sam Eldessouky completed an administrative equity transaction on 25-Jul-2025. Exactly 3,996 common shares were withheld by the company (transaction code “F”) at an indicated price of $14.32 to cover tax obligations triggered by the vesting of restricted share units. No open-market buying or selling occurred.

After the tax-settlement, Eldessouky’s direct beneficial ownership stands at 278,299 BLCO shares. The filing lists no derivative security activity and leaves his overall stake largely unchanged. Because the shares were surrendered to the issuer rather than sold to investors, the event is considered routine and is unlikely to influence the stock’s supply-demand dynamics or signal a change in the executive’s outlook.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine tax-withholding; negligible ownership change, neutral market impact.

The Form 4 indicates a standard RSU vesting settlement. Only 1.4 % of Eldessouky’s stake was surrendered, and the shares never reached the open market. Such code F transactions typically have no valuation signal and do not alter insider sentiment. The executive still holds a sizable 278k-share position, preserving alignment with shareholders. I classify the filing as operationally immaterial and do not adjust my view of BLCO’s insider activity trend.

TL;DR: Administrative compliance; governance posture unchanged.

From a governance standpoint, timely disclosure of RSU-related withholding reflects proper Section 16 compliance. No red flags emerge: there is no discretionary sale, no pattern of large disposals, and insider ownership remains substantial. The event neither strengthens nor weakens governance quality; it simply documents obligatory tax settlement mechanics.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Eldessouky Sam

(Last) (First) (Middle)
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT

(Street)
VAUGHAN A6 L4K 4B4

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and CFO
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, No Par Value 07/25/2025 F 3,996(1) D $14.32 278,299 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.
/s/ Debra E. Levin, attorney-in-fact 07/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BLCO's Form 4 report on 25-Jul-2025?

It reported CFO Sam Eldessouky had 3,996 shares withheld to cover taxes on vested RSUs.

Was there an open-market sale of BLCO shares by the CFO?

No. The transaction code “F” indicates shares were surrendered to the company, not sold publicly.

How many BLCO shares does the CFO now own?

After the transaction, Eldessouky directly owns 278,299 common shares.

At what price were the withheld shares valued?

The shares were valued at $14.32 each for tax-withholding purposes.

Does this Form 4 filing signal a change in insider sentiment?

Likely not; code F filings are routine tax events and generally neutral regarding insider outlook.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

5.99B
38.54M
88.06%
11.29%
0.91%
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN